
Huntsman came into this Q3 2026 report looking like a classic recovery story, with the stock up about 12% over the past month. The headline result was another quarterly loss, with basic earnings per share at a loss of US$0.09 on revenue of US$1,717 million, and the market did not wait to pass judgment. The share price dropped about 4% on the day.
The central issue is profitability. Trailing twelve month net income from continuing operations remains in the red at US$107 million of losses, even as management highlights merger synergies and cost programs. For investors, that gap between turnaround expectations and current earnings power is what stands out this quarter.
Like the Huntsman story but uneasy about another quarterly loss and ongoing red ink on the bottom line? Check out the list of solid balance sheet and fundamentals stocks (24 results).
Prefer interactive charts instead of another wall of Huntsman earnings tables and raw figures? Get a clear visual view of the company’s full financial picture, with a particular focus on its recent profitability trend, in the company report for Huntsman.
For the bullish story to work, Huntsman has to show that merger execution and cost work are more than a slide in a deck.
"The main factor that needs to go right is successful execution of the Olin merger and ongoing footprint rationalization, so that the identified cost synergies and European restructuring benefits are realized without eroding core polyurethane and advanced materials demand."
Q3 moves in this direction. The firm reported over US$100 million of 2026 EBITDA improvement versus 2025 and Q3 cost actions helped shrink the loss despite soft housing and Europe. European polyurethanes returned to EBITDA positive territory and Advanced Materials volumes grew about 12%. On the merger itself, shareholder and regulatory milestones are in hand and closing is guided for early 2027, so the preparatory work is largely on track.
One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all.
Bearish investors worry Huntsman will struggle to squeeze real cash out of the Olin deal rather than just talk about it.
"Although the planned Olin merger is framed around more than US$400 million of annual cost and integration synergies, the recent share price declines of roughly 17 to 20% in mid June and another 17% after the Q2 2026 release highlight that any delay, shortfall or cost overrun in delivering the targeted US$300 million of early synergies and later raw material integration could leave Huntsman with structurally higher costs and weaker EBITDA than many investors currently model."
Recent Q3 numbers show over US$100 million of 2026 EBITDA improvement versus 2025 and Q3 free cash flow of US$82 million, which points to some cost work landing. Yet the stock fell about 4% on the day and still trades only slightly above the US$9 bearish fair value marker. That reaction suggests the market is not yet rewarding the US$300 million synergy plan and is treating the headline progress on merger milestones as necessary but not sufficient proof that the structural cost story is de risked.
Huntsman reports results that show how busy earnings updates can still leave profit trends unclear. The real opportunity is finding stocks that could be undervalued before the market corrects them.
Those are three of them. See the full list of 34 companies trading below our fair value estimates →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com